HR 1060 119th Congress House In Committee

Modern Authentication of Pharmaceuticals Act of 2025

Latest action: Referred to the House Committee on Energy and Commerce. · Feb 6, 2025

View full text on Congress.gov ↗ Policy area: Health

Legislative Summary

Modern Authentication of Pharmaceuticals Act of 2025 This bill requires each dose of a pharmaceutical product that is a controlled substance and that is taken orally in solid form (i.e., pills) to include a physical chemical identifier. (Physical chemical identifiers are substances that possess a unique physical or chemical property, such as inks, pigments, flavors, and molecular taggants, that unequivocally identify and authenticate a drug or dosage.) Under the bill, physical chemical identifiers must be included in or on the product and must be machine readable. The bill applies to products manufactured beginning five years after the bill's enactment.

Source: Congressional Research Service (CRS).

Sponsor
Rep. Davis, Donald G. [D-NC-1]
Independent · NC
Cosponsors (3)
Rep. RutherfordRep. BaconRep. Fitzpatrick

Track HR 1060 in BallotBox360

Get real-time bill updates, floor vote alerts, and AI-powered summaries — all in one app.

Download on iOS Open Web App